eFFECTOR Therapeutics, Inc. - EFTR

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2024 · Q1 2024
Value (USD)
Total reported value ($000)
$201K
QoQ value delta ($000)
-$7.908M (-97.52%)
Implied price effect (QoQ)
-98.02%
Shares
Total shares
710,647
QoQ shares delta
+143,141 (+25.22%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (EFTR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2024)

Top 25 only Full list
Early Q3 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Alyeska Investment Group, L.P. 105 364,934 0.0%
Carlyle Group Inc. 55 192,884 0.01%
UBS Group AG 17 61,667 0.0%
VANGUARD GROUP INC 7 25,070 0.0%
GEODE CAPITAL MANAGEMENT, LLC 7 25,583 0.0%
JANE STREET GROUP, LLC 5 18,669 0.0%
TWO SIGMA INVESTMENTS, LP 3 11,115 0.0%
Tower Research Capital LLC (TRC) 2 9,805 0.0%
BANK OF AMERICA CORP /DE/ 0 31 0.0%
BARCLAYS PLC 0 100 0.0%
MORGAN STANLEY 0 240 0.0%
ROYAL BANK OF CANADA 0 546 0.0%
Qube Research & Technologies Ltd 0 3 0.0%